You are here: Industry Insights > Migraine

News List

Pfizer recalls migraine med Relpax because of bacterial contamination fiercepharma
August 18, 2019
After an earlier recall of Relpax, Pfizer is again tracking down a couple of lots of the migraine headache med.
Evidence Supports Meds Used for Pain Relief in Pediatric Migraine drugs
August 15, 2019
Evidence-based therapies are available for the acute symptomatic treatment of migraine in children and adolescents, but evidence is lacking for the impact of many treatments for migraine prevention...
Excess Caffeine May Be a Trigger for Episodic Migraine Headaches drugs
August 12, 2019
Higher levels of caffeinated beverage intake may be a trigger for migraine headache on that day among adults with episodic migraines, according to a study published Aug. 8 in the American Journal of Medicine.
How Much Coffee Is Too Much for Migraine Sufferers? drugs
August 09, 2019
If you have migraines, one or two cups of coffee a day may be okay, but three or more could raise your risk of an attack, a new study concludes.
Biohaven Completes Enrollment in Phase 3 Migraine Prevention Trial americanpharmaceuticalreview
August 09, 2019
Biohaven has reported completion of enrollment in its pivotal Phase 3 preventive treatment of migraine trial with rimegepant, its lead oral calcitonin gene-related peptide (CGRP) receptor antagonist product candidate.
Emgality maker Lilly courts payers with new migraine ER data fiercepharma
July 13, 2019
Sales of Eli Lilly’s migraine and cluster headache med Emgality have lagged behind competitors from Amgen and Novartis and Teva Pharmaceutical. And in its push to bring payers on board, Lilly is deploying a full-court press with some new patient data.
New Migraine Drug, Rimegepant (Not Yet Approved) Might Help When Other Meds Don't drugs
July 11, 2019
A new migraine drug might offer an alternative to people who do not get relief from current medications, a new trial suggests.
Adverse Outcomes Up for Pregnant Women With Migraine drugs
July 03, 2019
Pregnant women with migraine and their offspring have increased risks of several adverse pregnancy and neonatal outcomes, according to a study recently published in Headache.
AHA News: What Migraine Sufferers Need to Know About Stroke Risk drugs
June 24, 2019
What Migraine Sufferers Need to Know About Stroke Risk.
Novartis to globally co-commercialise Amgen’s migraine drug europeanpharmaceuticalreview
May 07, 2019
Novartis has expanded their commercialisation agreement with Amgen for AMG 334 (erenumab), which is being investigated for the prevention of migraine…

Previous page 1 2 3 4 5 6 7 8 9 Next page